For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...

A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DNA, it rewires how genes are turned on and off, helping ...

Neuroendocrine cells are unique in their ability to act both as nerve cells and hormone-making cells.They're scattered throughout the body, including ...

HMC performed its first robotic Whipple procedure on a 42-year-old woman diagnosed with a pancreatic head neoplasm.

Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate. It ...

A recent meta-analysis reveals that artificial sweeteners do not increase the risk of cancer, despite years of skepticism.

There’s no denying how impressive the human body is. It can be incredibly strong, capable of pulling off amazing feats at the ...

According to the National Institutes of Health, nearly one in three adults in the US are overweight (30.7 per cent). Aside ...

The FDA has approved Foundayo, a new weight-loss pill that could give Eli Lilly an edge over other drugmakers. Here's how it ...

A fast-casual and a sit-down restaurant are slated to open in Phoenix's West Valley, serving Mexican and wood fired Latin ...

More incidental pancreatic cysts are being found with modern imaging; physicians must weigh MRI surveillance against high risk surgery based on size, growth, and duct dilation.

Far fewer Medicare Advantage patients underwent complex procedures - like pancreatic- or stomach-cancer surgeries - at high-quality centers. The gap in the kind of coverage these patients seek is ...